Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV003490107 | SCV004242095 | uncertain significance | not specified | 2023-12-08 | criteria provided, single submitter | clinical testing | Variant summary: SNORD118 n.75A>C alters a conserved nucleotide in a non-coding RNA gene. The variant allele was found at a frequency of 6.6e-06 in 759978 control chromosomes (i.e. in 5 carriers) in the gnomAD database, v4.0 dataset. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. The variant, n.75A>C (aka. TMEM107 c.*689A>C), has been reported in the literature in a compound heterozygous individual affected with Leukoencephalopathy with Calcifications And Cysts (Crow_2021, Politano_2023). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, a different variant affecting the same nucleotide has been also reported in a patient (see Crow_2021, Politano_2023, and PMIDs 27571260, 28748214), suggesting that this nucleotide position might be important for RNA structure/function. The following publications have been ascertained in the context of this evaluation (PMID: 33029936, 37761957). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
| Laboratory of Neurogenetics and Neuroinflammation, |
RCV001194488 | SCV001364113 | pathogenic | Leukoencephalopathy with calcifications and cysts | 2020-04-06 | no assertion criteria provided | clinical testing |